» Articles » PMID: 31069198

Predictors of Adverse Drug Reactions in Geriatric Patients: An Exploratory Study Among Cancer Patients

Overview
Specialty Oncology
Date 2019 May 10
PMID 31069198
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The objective of this study was to study the predictors of adverse drug reactions (ADRs) among geriatric patients in the Department of Medical Oncology.

Methods: A hospital-based prospective observational study was carried out among 153 inpatients in the Department of Medical Oncology for 6 months. Patients above 60 years of age with a confirmed history of malignancy were included in the study. The potential risk factors for ADR were defined in relation to the patient and chemotherapeutic regimen and relationship between them was assessed by univariate and multivariate logistic regression analysis.

Results: Among 153 patients, 94 (64.43%) experienced ADRs. The mean ADR per patient was 0.88 ± 1.2. The common ADRs found were alopecia (30.18%) and diarrhea (28.68%). Risk estimates revealed that there was a significant association between smokers (odds ratio [OR] = 10.326; 95% confidence interval [CI] 2.345-45.47, = 0.001), alcoholics (OR = 10.897; 95% CI 2.479-47.902, = 0.001), increasing age (OR = 2.22; 95% CI 1.698-2.909, = 0.001), overweight (OR = 16.68; 95% CI 2.179-127.741, = 0.001), and male participants (OR = 0.143; 95% CI 0.05-0.390 = 0.001) with the development of ADRs. The risk of carboplatin (OR = 13.359; 95% CI 3.056-58.406 = 0.001) and 5-fluorouracil (OR = 1.938 95% CI 1.266-2.935 = 0.001) use and occurrence of ADRs were also found to be high.

Conclusion: The study findings showed that smoking, alcohol consumption, age more than 70 years, and overweight had a high risk for developing ADRs in geriatric patients who underwent chemotherapy. The independent risk factors identified should be targeted for preventive measures to improve anticancer agent prescription and reduce the risk of ADRs.

Citing Articles

Predictors of hospital-acquired adverse drug reactions: a cohort of Ugandan older adults.

Yadesa T, Kitutu F, Tamukong R, Alele P BMC Geriatr. 2022; 22(1):359.

PMID: 35461224 PMC: 9033930. DOI: 10.1186/s12877-022-03003-9.


Development and Validation of 'Prediction of Adverse Drug Reactions in Older Inpatients (PADROI)' Risk Assessment Tool.

Yadesa T, Kitutu F, Tamukong R, Alele P Clin Interv Aging. 2022; 17:195-210.

PMID: 35241911 PMC: 8888137. DOI: 10.2147/CIA.S350500.


Challenges Faced by Clinicians in the Personalized Treatment Planning: A Literature Review and the First Results of the Russian National Cancer Program.

Shegai P, Shatalov P, Zabolotneva A, Falaleeva N, Ivanov S, Kaprin A Crit Care Res Pract. 2021; 2021:6649771.

PMID: 34603796 PMC: 8483928. DOI: 10.1155/2021/6649771.


Prevalence, Incidence, and Characteristics of Adverse Drug Reactions Among Older Adults Hospitalized at Mbarara Regional Referral Hospital, Uganda: A Prospective Cohort Study.

Yadesa T, Kitutu F, Tamukong R, Alele P Clin Interv Aging. 2021; 16:1705-1721.

PMID: 34588772 PMC: 8473935. DOI: 10.2147/CIA.S332251.


Prevalence, characteristics and predicting risk factors of adverse drug reactions among hospitalized older adults: A systematic review and meta-analysis.

Yadesa T, Kitutu F, Deyno S, Ogwang P, Tamukong R, Alele P SAGE Open Med. 2021; 9:20503121211039099.

PMID: 34422271 PMC: 8377309. DOI: 10.1177/20503121211039099.

References
1.
Bowie M, Slattum P . Pharmacodynamics in older adults: a review. Am J Geriatr Pharmacother. 2007; 5(3):263-303. DOI: 10.1016/j.amjopharm.2007.10.001. View

2.
Lichtman S, Boparai M . Anticancer drug therapy in the older cancer patient: pharmacology and polypharmacy. Curr Treat Options Oncol. 2008; 9(2-3):191-203. DOI: 10.1007/s11864-008-0060-6. View

3.
Silva T, Jerussalmy C, Farfel J, Curiati J, Jacob-Filho W . Predictors of in-hospital mortality among older patients. Clinics (Sao Paulo). 2009; 64(7):613-8. PMC: 2710432. DOI: 10.1590/S1807-59322009000700002. View

4.
Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2011; 127(12):2893-917. DOI: 10.1002/ijc.25516. View

5.
Maggiore R, Gross C, Togawa K, Tew W, Mohile S, Owusu C . Use of complementary medications among older adults with cancer. Cancer. 2012; 118(19):4815-23. PMC: 3366170. DOI: 10.1002/cncr.27427. View